EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer

Published:2008-07-01 Issue:13 Volume:14 Page:4275-4283
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Koivunen Jussi P.,Mermel Craig,Zejnullahu Kreshnik,Murphy Carly,Lifshits Eugene,Holmes Alison J.,Choi Hwan Geun,Kim Jhingook,Chiang Derek,Thomas Roman,Lee Jinseon,Richards William G.,Sugarbaker David J.,Ducko Christopher,Lindeman Neal,Marcoux J. Paul,Engelman Jeffrey A.,Gray Nathanael S.,Lee Charles,Meyerson Matthew,Jänne Pasi A.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 863 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non-small cell lung cancer;Lung Cancer;2024-09

2. Cancer-associated fibroblasts confer ALK inhibitor resistance inEML4-ALK-driven lung cancer via concurrent integrin and MET signaling;2024-08-28

3. A CRISPR activation screen identifies FBXO22 supporting targeted protein degradation;Nature Chemical Biology;2024-07-04

4. Real‐world evidence of brigatinib as second‐line treatment after crizotinib for ALK+ non‐small cell lung cancer using South Korean claims data (K‐AREAL);Cancer Medicine;2024-07

5. Fusion Genes Landscape of Lung Cancer Patients From Inner Mongolia, China;Genes, Chromosomes and Cancer;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP